Future Funding

AUROTECH ultrasound AS is expecting a positive cash flow from operating activities (revenue from OEM units, licenses and development projects) from 2013 with today’s activity level. The company’s management and board of directors are constantly evaluating the need for increased capacities in all areas, but have always built the company patiently, focusing on long-term targets. Future capacity and funding needs are also closely related to new contracts. The company has so far focused on medtech customers and is in contact with several interesting companies. AUROTECH has also introduced MANUS to some of the larger ultrasound companies and with promising feedback. The company’s target of three new medtech customers each year and a long term contract with some of the larger ultrasound companies seems very obtainable. Further development of the company will also be discussed with potential new investors.